ArticleMolecular pharmacology2019

Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma.

Nicole L Michmerhuizen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.